These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2985740)

  • 21. The flavin inhibitor diphenyleneiodonium renders Trichomonas vaginalis resistant to metronidazole, inhibits thioredoxin reductase and flavin reductase, and shuts off hydrogenosomal enzymatic pathways.
    Leitsch D; Kolarich D; Duchêne M
    Mol Biochem Parasitol; 2010 May; 171(1):17-24. PubMed ID: 20093143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
    Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
    Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative pathway of metronidazole activation in Trichomonas vaginalis hydrogenosomes.
    Hrdý I; Cammack R; Stopka P; Kulda J; Tachezy J
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5033-6. PubMed ID: 16304169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaginal PO2 in healthy women and in women infected with Trichomonas vaginalis: potential implications for metronidazole therapy.
    Rashad AL; Toffler WL; Wolf N; Thornburg K; Kirk EP; Ellis G; Whitehead WE
    Am J Obstet Gynecol; 1992 Feb; 166(2):620-4. PubMed ID: 1536244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Metronidazole resistance test in vitro in strains of Trichomonas vaginalis isolated from clinical material. 1. Test conditions].
    Tachezy J; Kulda J
    Cesk Epidemiol Mikrobiol Imunol; 1991 Mar; 40(2):89-96. PubMed ID: 1827366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A reassessment of the role of oxygen scavenging enzymes in the emergence of metronidazole resistance in trichomonads.
    Gehl V; Paunkov A; Leitsch D
    Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():38-44. PubMed ID: 33962363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity.
    Malla N; Kaul P; Sehgal R; Gupta I
    Indian J Med Microbiol; 2011; 29(2):152-7. PubMed ID: 21654110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of free radicals from metronidazole and other nitroimidazoles by Tritrichomonas foetus.
    Moreno SN; Mason RP; Muniz RP; Cruz FS; Docampo R
    J Biol Chem; 1983 Apr; 258(7):4051-4. PubMed ID: 6300071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro studies on the identification of metronidazole resistant strains of Trichomonas vaginalis (author's transl)].
    Meingassner JG; Stockinger K
    Z Hautkr; 1981 Jan; 56(1):7-15. PubMed ID: 6971538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in vitro sensitivity to metronidazole of Trichomonas vaginalis with isolates and clones.
    Sithithaworn P; Sithithaworn J; Kitjaroen K; Pairojkul C; Ratananurakpong S; Sriswangwonk T
    Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):279-84. PubMed ID: 2609217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica.
    Moya IA; Su Z; Honek JF
    Future Med Chem; 2009 Jul; 1(4):619-43. PubMed ID: 21426030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro susceptibility of Trichomonas vaginalis to AT-specific minor groove binding drugs.
    Chavalitshewinkoon-Petmitr P; Ramdja M; Kajorndechakiat S; Ralph RK; Denny WA; Wilairat P
    J Antimicrob Chemother; 2003 Aug; 52(2):287-9. PubMed ID: 12837730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis.
    Blaha C; Duchêne M; Aspöck H; Walochnik J
    J Antimicrob Chemother; 2006 Feb; 57(2):273-8. PubMed ID: 16344287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ferredoxin-dependent reduction of nitroimidazole derivatives in drug-resistant and susceptible strains of Trichomonas vaginalis.
    Yarlett N; Yarlett NC; Lloyd D
    Biochem Pharmacol; 1986 May; 35(10):1703-8. PubMed ID: 3486660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study on the in vitro susceptibility of Trichomonas vaginalis to metronidazole.
    Lin PR; Shaio MF
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1994 Feb; 27(1):38-45. PubMed ID: 9747331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metronidazole inactivation by aerobes.
    Edwards DI; Shanson D
    J Antimicrob Chemother; 1980 May; 6(3):402-3. PubMed ID: 6995421
    [No Abstract]   [Full Text] [Related]  

  • 38. Intravenous therapy of metronidazole-resistant Trichomonas vaginalis.
    Dombrowski MP; Sokol RJ; Brown WJ; Bronsteen RA
    Obstet Gynecol; 1987 Mar; 69(3 Pt 2):524-5. PubMed ID: 3492696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The crystal structure of Trichomonas vaginalis ferredoxin provides insight into metronidazole activation.
    Crossnoe CR; Germanas JP; LeMagueres P; Mustata G; Krause KL
    J Mol Biol; 2002 Apr; 318(2):503-18. PubMed ID: 12051855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine pathogenicity of Trichomonas vaginalis & its susceptibility to metronidazole.
    Jayarao P; Gogate A; Deodhar L
    Indian J Med Res; 1991 Mar; 93():90-4. PubMed ID: 1855825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.